Member Info for Bluebelly

I'm with Rockz on this. BM03 we have dropped from 105p to 69p over a few months and we were under valued then.
If the Algo's are reversed the rise will be a lot quicker to fair value. Then news flow for the next level of valuation.
Opening up from lock down regulations could be a catalyst for a reversal through a massive spike in Covid positive testing and the increased hospitalisations.
We are not just covid related though, we have many strings to our bow.

BB

Could be good or bad:
'Usually, stocks wind up on the pink sheets for failure to meet SEC requirements for listing on larger stock exchanges, such as lacking financial information or their stock price falling below one dollar.
We have no financial information!
'Tencent (OTCMKTS:TCEHY) has become the largest OTC stock trading today. With a $398 billion market cap, the Shenzhen and Cayman Islands-based conglomerate has grown into one of the world's largest companies'
OTCPK - An Over the counter pinks listing can be spun either way. Lets wait for next week and see where this is.

BB

Good luck with your 10%, I can see it hitting the high 70's soon.

BB

I find it hard to see why the two companies would participate in that size purchase of shares and then sell out at a big loss before any concrete news/success is achieved. They are normally more forward looking than that.
Everyone spoke of the Due Diligence they must have carried out, when they bought in at £2.05 ish. 4 months later they're gone. It's was thought by some that they were in for the Acustem shares, but now it appears they are not entitled to those either. So in effect they saw value in TILS at £2.05 without any Acustem. Maybe they sold their ADR's to the Oncotype DX company?
More Conspiracy theories.

BB

Just for clarity: I mentioned Loan notes in my reply to Yuri.F, as he stated:
'a) printing shares every year
b) making losses'
I have written it again in a clearer manner.
Yuri.F - We could have gone down the route of a joint venture with a big pharma and give away 50% of the future £billions of value this company is likely to have.
Yuri.F - How would you raise money for research?
Would it be through Loan notes with warrants attached? ( This is normally a good way to write a company off through dilution and pretty quickly).

IMHO, TILS raised money at a high price as did many Pharmas, well done.
I believe governments made money available to medical research companies through Investment houses.
They dish out $m's to various Pharma's researching Covid etc via investment houses, the prices are elevated, shares are issued, then investment houses sell the shares below the issue price and return the leftover cash to the governments minus their fees.
With TILS $57m raise, the shares could have been sold on the way down at an average of 150p, approx 25% down. Cost to Governments ends up being massively reduced ( may be $17m to fund the $57m ). PI's left holding the loss, unless they have a break through.

BB

Yuri.F
We could have joint venured with a big pharma and given 50% of £billions away.
How would you raise money for research?
Loan notes with warrants attached normally write a company off through dilution pretty quickly!

BB

I guess we need a ticker code for the Nasdaq ADR's and our holding should then be divided by two and held as ADR's in our account, so people who want to sell can then sell or buy more.

BB

Pilgrim : 'idiots that know zero about how business operates and how intensive it is to carry out a share split.'
I'm not here to argue for or against, or to whine, however from the statement above you appear to know how hard it is to carry out a de-merger.
So extrapolating from your comment, do you believe the initial 60 days timeline form the end of October to complete the process was inadequate as a time scale that was given via RNS to the shareholders.
In my industry we raise contracts for specialist tasks that is beyond our skill level or manpower and there are penalties if timelines are not met.
Is the Acustem delay the fault of the management or the advisers. The only one penalized thus far are the shareholders. I've accepted this, however, the most disappointing aspect for me is the total disregard wrt updating shareholders when deadlines are missed. More information was gained from Zacks Target Price update (ie, Q3 completion) than was released in an RNS.

Still holding strong.

BB

If they have caused the two holders from the fund raise to miss out on Acustem shares, Altium and Empery will be spreading the word, if they're not taking legal action, unless they were aware of the Nasdaq rules for this process and accepted they would not be entitled.
We shall find out soon enough.

BB

BB

Nasdaq TLSA is trading. It's around 76p
Almost parity and neither TILS or TLSA have Acustem shares entitlement when buying today.

BB

Are TLSA suspended?

BB

That looks like they have cut & pasted from the original demerger RNS. The reason why we expected Acustem to be listed around end of December 20 or before!

BB

The first patient with SPMS was dosed on May 24, 2021 with nasally administered Foralumab. The treatment regimen will continue for six months to examine long-term safety, tolerability and clinical responses. - 7 Weeks of data.

Tiziana Announces Strategic Initiative with Takanawa Japan K.K., Pharma Team, to Identify a Partner in Japan and Other Asian Countries for Further Clinical Development of Milciclib in Patients with Advanced Hepatocellular Carcinoma. - RNS'd over two months ago.

Phase 2 Clinical Trial for Treating Hospitalized Severe COVID-19 Patients with Intranasal Foralumab. to conduct a Phase 2 Proof-of-concept study in Brazil to evaluate the safety, tolerability and efficacy of intranasal Foralumab in hospitalized patients with severe coronavirus disease 2019 (COVID-19) and pulmonary inflammation. Nearly 3 weeks ago.

And Acustem will hopefully be on a separate board in the not to distant future. 19th ish.

BB

Lets hope a reversal starts soon.

BB

Acustem is the Dividend = DR/Depository Receipt.
I believe the date for ADR's to be entitled to Acustem was 6th Nov 20.
I do remember reading something about the holders should pass on their entitlement if they sold their shares. But cannot remember the dates.

BB

Is there nothing showing for Corporate Actions. Account drop down - top right. select - Document History. Select Corporate Actions.
Apologies if you've already done this.

BB

From II Corporate Actions:
' you should receive the new Accustem shares on or after the 8th July 2021. Accounts will be updated upon receipt of the
stock from the company.'
Be patient, you'll get them, but they can't be traded yet anyway.

BB

From TILS website: 'In light of the coronavirus pandemic the Company is accelerating GMP manufacturing of its anti-IL-6R mAb concurrently with developing an inhalation technology for direct delivery of the antibody into the lungs using a handheld inhaler or nebulizer for treatment of patients with COVID-19.'

Again we are ahead of the curve, yet left high and dry. Tocilizumab and Sarilumab are approved by the FDA however these are dosed by IV and subcutaneous injection respectively.

TILS get your PR machine in action, or is it all to do with large brown envelopes?

BB

WHO link: https://www.who.int/news/item/06-07-2021-who-recommends-life-saving-interleukin-6-receptor-blockers-for-covid-19-and-urges-producers-to-join-efforts-to-rapidly-increase-access

BB

I don't think we will see a price until the 19th July, when all holders will have received their entitlement and they can start trading.
The only fair way - IMHO

BB